A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors

Memorial Sloan Kettering Cancer Center (MSK)

Status: Enrolling

Conditions: Ocular Tumor

Treatments: Diagnostic Test: Heidelberg Spectralis OCT; Diagnostic Test: Intalight Dream OCT

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT07449195

25-314

Details and patient eligibility

About

The purpose of this study is to compare two devices used for optical coherence tomography (OCT). OCT is a noninvasive imaging (scanning) method that uses reflected light to create pictures of the back of the eye, and doctors can use OCT to detect and monitor different types of cancer

Enrollment: 60 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥18 years.
• At least 1 eye that has an intraocular or ocular surface tumor.
• The presence of a natural crystalline lens or intraocular lens.
• Pupils that can dilate up to at least 3 mm in the study eyes.
• The absence of opaque natural crystalline lenses or the presence of any ocular disease that prevents the view of the retina for imaging.
• Patients must be able to fixate on the imaging target.
• Patients must be able to sit still for a period of time (approximately 2 minutes).

Exclusion criteria

• Does not meet ALL of the above conditions

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

60 participants in 1 patient group

Participants with Ocular Tumor

Experimental group

Description:

Participants will have at least 1 eye that has an intraocular or ocular surface tumor.

Treatment:

Diagnostic Test: Intalight Dream OCT

Diagnostic Test: Heidelberg Spectralis OCT